Award recordCONTRACT

TALECRIS BIOTHERAPEUTICS HOLDINGS CORP.

PIID VA24813F1189· VHA· 248-NETWORK CONTRACT OFFICE 8· 6505 · DRUGS AND BIOLOGICALS· FY2013· $236,009 net obligations· UEI CRPPBSL435G7· NC

Description

PROLASTIN DRUG DIRECT PATIENT CARE - EMERGENCY

First action · last action
2012-10-09 · 2014-01-14
Transactions
3
First transaction's obligation
$50,000
Base + all options value (sum of deltas)
$236,009
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5820X
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$275,000$0Base award · 2012-10-09 · this action $50,000 · running total $50,000Modification P00001 · 2013-01-31 · this action $225,000 · running total $275,000Modification P00002 · 2014-01-14 · this action -$38,991 · running total $236,009
  • Base2012-10-09+$50,000= $50,000
  • Mod P000012013-01-31+$225,000= $275,000
  • Mod P000022014-01-14-$38,991= $236,009
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2012-10-09+$50,000$50,000PROLASTIN DRUG DIRECT PATIENT CARE - EMERGENCY
Mod P00001· CHANGE ORDER2013-01-31+$225,000$275,000PROLASTIN DRUG DIRECT PATIENT CARE - EMERGENCY
Mod P00002· CHANGE ORDER2014-01-14−$38,991$236,009PROLASTIN DRUG DIRECT PATIENT CARE - EMERGENCY

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI CRPPBSL435G7)

AwardOffice · PSC / listingNet obligationsFY
VA25716J0121257-NETWORK CONTRACT OFFICE 17 · 6505 · DRUGS AND BIOLOGICALS$8,004FY2016
VA25115F2931515-BATTLE CREEK(00515) · Q999 · MEDICAL- OTHER$109,346FY2016
VA25715J3074257-NETWORK CONTRACT OFFICE 17 · 6505 · DRUGS AND BIOLOGICALS$7,880FY2015
VA25715J2849257-NETWORK CONTRACT OFFICE 17 · 6810 · CHEMICALS$3,881FY2015
VA24615F6283246-NETWORK CONTRACTING OFFICE 6 · 6505 · DRUGS AND BIOLOGICALS$5,482FY2015
VA25715J1397671-SAN ANTONIO · 6505 · DRUGS AND BIOLOGICALS$7,344FY2015

Other recipients under 6505 from 248-NETWORK CONTRACT OFFICE 8 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA24816J2789CSL BEHRING L.L.C.248-NETWORK CONTRACT OFFICE 8$25,056FY2016
VA24816J2780CSL BEHRING L.L.C.248-NETWORK CONTRACT OFFICE 8$102,089FY2016
VA24816F1279CSL BEHRING L.L.C.248-NETWORK CONTRACT OFFICE 8$22,016FY2016
VA24816P1268MCKESSON CORPORATION248-NETWORK CONTRACT OFFICE 8$16,913FY2016
VA24816P1163MCKESSON CORPORATION248-NETWORK CONTRACT OFFICE 8$10,115FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24813F1189_3600_V797P5820X_3600 · retrieved 2026-09-26.